We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.83%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$853M
AUM Growth
+$41.2M
(+5.1%)
Cap. Flow
-$4.27M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
45.97%
Holding
2,993
New
166
Increased
1,040
Reduced
961
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$12.7M |
| 2 |
RPAR Risk Parity ETF
RPAR
|
+$5.28M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$4.15M |
| 4 |
Bank of America
BAC
|
+$4.06M |
| 5 |
NVIDIA
NVDA
|
+$3.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oramed Pharmaceuticals
ORMP
|
+$4.61M |
| 2 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$4.54M |
| 3 |
First Trust Global Tactical Commodity Strategy Fund
FTGC
|
+$4.45M |
| 4 |
iShares US Oil & Gas Exploration & Production ETF
IEO
|
+$4.15M |
| 5 |
AGEN
Agenus
AGEN
|
+$2.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.04% |
| 2 | Technology | 13.3% |
| 3 | Healthcare | 7.37% |
| 4 | Industrials | 3.43% |
| 5 | Consumer Staples | 3.24% |
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Lindbrook Capital held 2,993 positions worth $853M, up 5.1% from $812M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital's Q1 2023 filing shows 166 new, 1,040 increased, 961 reduced and 220 closed positions. Its largest new stake was Hess Midstream: 4,984 shares worth $144K. The largest sale was Oramed Pharmaceuticals, an estimated $4.61M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.
- Lindbrook Capital's largest Q1 2023 buy was Hess Midstream: 4,984 shares worth $144K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q1 2023, an estimated $12.7M increase.
- Lindbrook Capital's biggest Q1 2023 reduction was Agenus, cutting an estimated $2.89M.
- Lindbrook Capital fully exited Oramed Pharmaceuticals in Q1 2023, selling an estimated $4.61M.
- Lindbrook Capital's ten largest holdings make up 46% of its $853M portfolio in Q1 2023.
- Lindbrook Capital opened 166 new positions and closed 220 in Q1 2023.
- Lindbrook Capital's portfolio value rose 5.1% quarter-over-quarter to $853M.
Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.